Phosphodiesterase-5 Inhibitor Attenuates Anxious Phenotypes and Movement Disorder Induced by Mild Ischemic Stroke in Rats

CONCLUSION: PDE5i as effective therapeutic agents for anxiety and movement disorders and provide robust preclinical evidence to support the development and use of PDE5i for the treatment of mild ischemic stroke residual disorders.PMID:35430790 | DOI:10.3340/jkns.2021.0101

Source: Journal of Korean Neurosurgical Society - April 18, 2022 Category: Neurosurgery Authors: Yeon Hee Yu Seong-Wook Kim Juhyeon Kang Yejin Song Hyuna Im Seo Jeong Kim Dae Young Yoo Man-Ryul Lee Dae-Kyoon Park Jae Sang Oh Duk-Soo Kim Source Type: research